196 related articles for article (PubMed ID: 29977927)
1. Intravitreal Bevacizumab Injection Attenuates Diabetic Retinopathy in Adult Rats with Experimentally Induced Diabetes in the Early Stage.
Lv J; Chen MM; Mu ZH; Wang F; Qian ZY; Zhou L; Guo QT; Zhao ZM; Pan YP; Liao XY; Yang ZH; Cai N; Li SD; Zou YY
J Diabetes Res; 2018; 2018():9216791. PubMed ID: 29977927
[TBL] [Abstract][Full Text] [Related]
2. Effect of an intravitreal injection of bevacizumab on the expression of VEGF and CD34 in the retina of diabetic rats.
Ma J; Zhu T; Tang X; Ye P; Zhang Z
Clin Exp Ophthalmol; 2010 Dec; 38(9):875-84. PubMed ID: 20653693
[TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
Li J; Wang P; Ying J; Chen Z; Yu S
Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
[TBL] [Abstract][Full Text] [Related]
5. Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy.
Reddy SK; Ballal AR; Shailaja S; Seetharam RN; Raghu CH; Sankhe R; Pai K; Tender T; Mathew M; Aroor A; Shetty AK; Adiga S; Devi V; Muttigi MS; Upadhya D
Theranostics; 2023; 13(7):2241-2255. PubMed ID: 37153730
[TBL] [Abstract][Full Text] [Related]
6. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
7. Combination of Bevacizumab and NGF Reduces the Risk of Diabetic Retinopathy.
Zhang P; Zhou Z
Cell Biochem Biophys; 2015 Sep; 73(1):79-85. PubMed ID: 25666701
[TBL] [Abstract][Full Text] [Related]
8. Effect of intravitreal bevacizumab on macular thickness: exploring serum and vitreous proangiogenic biomarkers in patients with diabetic macular edema.
Malik TG; Ahmed SS; Gul R; Khalil M; Malik AA; Khan M
Turk J Med Sci; 2018 Aug; 48(4):833-839. PubMed ID: 30119160
[TBL] [Abstract][Full Text] [Related]
9. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
[TBL] [Abstract][Full Text] [Related]
10. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
11. CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA.
Hirano T; Toriyama Y; Iesato Y; Imai A; Murata T
Retina; 2018 Sep; 38(9):1801-1808. PubMed ID: 29280940
[TBL] [Abstract][Full Text] [Related]
12. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Alleviates Diabetic Retinopathy in Experimental Diabetic Rats.
Yang F; Yu J; Ke F; Lan M; Li D; Tan K; Ling J; Wang Y; Wu K; Li D
Ophthalmic Res; 2018; 60(1):43-54. PubMed ID: 29597206
[TBL] [Abstract][Full Text] [Related]
14. Trends of Anti-Vascular Endothelial Growth Factor Use in Ophthalmology Among Privately Insured and Medicare Advantage Patients.
Parikh R; Ross JS; Sangaralingham LR; Adelman RA; Shah ND; Barkmeier AJ
Ophthalmology; 2017 Mar; 124(3):352-358. PubMed ID: 27890437
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.
Hu B; Zhang Y; Zeng Q; Han Q; Zhang L; Liu M; Li X
Int J Mol Sci; 2014 Jan; 15(1):1606-24. PubMed ID: 24451141
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus.
Wang P; Chen F; Zhang X
BMC Pharmacol Toxicol; 2020 Feb; 21(1):9. PubMed ID: 32019593
[TBL] [Abstract][Full Text] [Related]
18. Ocular Anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy.
Simó R; Sundstrom JM; Antonetti DA
Diabetes Care; 2014 Apr; 37(4):893-9. PubMed ID: 24652720
[TBL] [Abstract][Full Text] [Related]
19. The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy.
Zhou W; Wang H; Yu W; Xie W; Zhao M; Huang L; Li X
PLoS One; 2017; 12(10):e0185795. PubMed ID: 28973045
[TBL] [Abstract][Full Text] [Related]
20. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
